Loading chart…

Incyte Corporation: “That one makes no sense that it’s down here. I think you got a really good one. I think you should maybe buy even more than you have. I don’t get it. This company actually makes money. It’s real good. I think the big boys are going to come to it. Nice call.”

Loading chart…

Nautilus Biotechnology: “That’s an Andreessen Horowitz-[backed] company. Look, this is one is too small for me to just point-blank say, ‘You’re absolutely right. We’ve got to love it.’ I’ve got to do more work on it. It does seem very strange because [Amazon founder Jeff] Bezos, it looks like they’re very involved . It’s an odd one. Let me do some work.”

Loading chart…

Corning: “They’re unassailable in terms of their manufacturing, but in terms of making money with that manufacturing, there are so many other better companies. I cannot recommend their stock.”

Loading chart…

Icahn Enterprises: “No. I think it’s variable, [which] is the problem. I don’t know what’s in Icahn Enterprises. He doesn’t tell us. I wish I knew, so therefore it’s too much of a black box for me to recommend.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

You May Also Like
Pfizer’s gene therapy for hemophilia A succeeds in late-stage trial

Pfizer’s gene therapy for hemophilia A succeeds in late-stage trial

Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said…

Ford is selling 8 million shares of once high-flying EV maker Rivian, sources say

In this article F RIVN Production of electric Rivian R1T pickup trucks…

Cramer’s week ahead: Next week sets the tone for all of earnings season

CNBC’s Jim Cramer on Friday looked ahead to the start of earnings season, focusing…
Pfizer weight loss pill joins list of obesity drug flops

Pfizer weight loss pill joins list of obesity drug flops

Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its…